Add time:07/31/2019         Source:sciencedirect.com

BackgroundTafenoquine (cas 106635-80-7) is a new prophylactic antimalarial drug. The current analysis presents an integrated safety assessment of the Tafenoquine Anticipated Clinical Regimen (Tafenoquine ACR) from 5 clinical trials, including 1 conducted in deployed military personnel and 4 in non-deployed residents, which also incorporated placebo and mefloquine comparator groups.

We also recommend Trading Suppliers and Manufacturers of Tafenoquine (cas 106635-80-7). Pls Click Website Link as below: cas 106635-80-7 suppliers